Fla. Admin. Code Ann. R. 64B16-27.820 - Patient Counseling
(1)
Upon receipt of a new or refill prescription, the pharmacist shall ensure that
a verbal and printed offer to counsel is made to the patient or the patient's
agent when present. If the delivery of the drugs to the patient or the
patient's agent is not made at the pharmacy the offer shall be in writing and
shall provide for toll-free telephone access to the pharmacist. If the patient
does not refuse such counseling, the pharmacist, or the pharmacy intern, acting
under the direct and immediate personal supervision of a licensed pharmacist,
shall review the patient's record and personally discuss matters which will
enhance or optimize drug therapy with each patient or agent of such patient.
Such discussion shall be in person, whenever practicable, by toll-free
telephonic communication, or by an interactive audio and digital image format,
and shall include appropriate elements of patient counseling. Such elements may
include, in the professional judgment of the pharmacist, the following:
(a) The name and description of the
drug;
(b) The dosage form, dose,
route of administration, and duration of drug therapy;
(c) Intended use of the drug and expected
action (if indicated by the prescribing health care practitioner);
(d) Special directions and precautions for
preparation, administration, and use by the patient;
(e) Common severe side or adverse effects or
interactions and therapeutic contraindications that may be encountered,
including their avoidance, and the action required if they occur;
(f) Techniques for self-monitoring drug
therapy;
(g) Proper
storage;
(h) Prescription refill
information;
(i) Action to be taken
in the event of a missed dose;
(j)
The potential for physical dependence, addiction, misuse, or abuse;
and
(k) Pharmacist comments
relevant to the individual's drug therapy, including any other information
peculiar to the specific patient or drug.
(2) Patient counseling as described herein,
shall not be required for inpatients of a hospital or institution where other
licensed health care practitioners are authorized to administer the
drug(s).
(3) A pharmacist shall not
be required to counsel a patient or a patient's agent when the patient or
patient's agent refuses such consultation.
Notes
Rulemaking Authority 465.022, 465.0155 FS. Law Implemented 465.0155 FS.
New 8-18-93, Formerly 21S-27.820, 61F10-27.820, 59X-27.820, Amended 7-11-18.
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.